2 not yet recruiting, 2 recruiting, 1 completed. 3 Early Phase 1, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Zhongmou Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of Novel Gene Therapy AGX-08 for Geographic Atrophy AGX-08-L, AGX-08-H, AGX-08-S - Geographic Atrophy | Early Phase 1 | Not yet recruiting | Zhongmou Therapeutics | 24 | 2026-07-01 | 2026-07-31 |
| Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy of Modified Optogenetic Gene Therapy (ZM-02 Injection) ZM-02 (low dose), ZM-02 (high dose), ZM-02 (selected dose) - Retinitis Pigmentosa (RP) | Phase 1 / Phase 2 | Not yet recruiting | Zhongmou Therapeutics | 21 | 2026-06-25 | 2026-04-13 |
| Natural History Study of Inherited Retinal Diseases Retinal Dystrophies, Color Vision Defects | Recruiting | Zhongmou Therapeutics | 200 | 2025-07-20 | 2025-12-10 | |
| Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients ZM-02-L, ZM-02-H, ZM-02-S - Retinitis Pigmentosa | Early Phase 1 | Recruiting | Zhongmou Therapeutics | 12 | 2024-02-25 | 2026-03-31 |
| Safety and Efficacy Study of Novel Gene Therapy ZM-01 for X-linked Retinoschisis Patients ZM-01-L, ZM-01-H - X-linked Retinoschisis | Early Phase 1 | Completed | Zhongmou Therapeutics | 2 | 2022-09-25 | 2026-03-31 |
Retinitis Pigmentosa (2) · Color Vision Defects (1) · Geographic Atrophy (1) · Macular Degeneration (1) · Retinal Dystrophies (1) · Retinoschisis (1) · Vision Disorders (1)
salicylhydroxamic acid (2) · Contraceptives, Oral (1)
China (3)
Wenbin Wei, PhD (1) · Yin Shen (1) · Yin Shen, PhD (1)